Quarterly ResultAug 6, 2026, 04:06 PM
Progyny Q2 Revenue $350.5M, Net Income $28.1M; Repurchases Shares
AI Summary
Progyny, Inc. reported record financial results for the second quarter of 2026, with revenue increasing 5.3% to $350.5 million and net income surging 64.3% to $28.1 million. The company also achieved record gross profit and Adjusted EBITDA, reflecting strong demand for its women's health and family building solutions. Additionally, Progyny returned value to shareholders by repurchasing nearly 1.2 million shares for $31.5 million during the quarter, with $142.5 million remaining under the current authorization. The company provided optimistic full-year 2026 guidance, projecting revenue between $1.360 billion and $1.385 billion.
Key Highlights
- Q2 2026 revenue increased 5.3% to $350.5 million.
- Q2 2026 gross profit rose 13% to $89.3 million, with gross margin at 25.5%.
- Q2 2026 net income grew 64.3% to $28.1 million, or $0.34 per diluted share.
- Q2 2026 Adjusted EBITDA increased 7.2% to $62.1 million.
- Repurchased nearly 1.2 million shares for $31.5 million in Q2 2026.
- Total clients reached 604 as of June 30, 2026, up from 542 in prior year.
- Full-year 2026 revenue guidance set at $1.360 billion to $1.385 billion.
- Full-year 2026 Adjusted EBITDA guidance is $233.0 million to $240.0 million.
Price Impact
More from PGNY